To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency

Clinical trial NCT06672276 · COMPLETED

Trial details

NCT number: NCT06672276
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Resistant to Gram-positive, Gram-negative and Anaerobic Bacteria

Start date: 2024-11-20
Primary completion: 2025-05-06
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.